Prosecution Insights
Last updated: October 25, 2026

Beijing Transcend Vivoscope Bio-Technology Co. Ltd.

1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Beijing Transcend Vivoscope Bio-Technology Co. Ltd. has 1 pending office action. The matter is assigned to 1 distinct examiner, BOOSALIS, FANI POLYZOS, who handles the pending action.

The profile lists 0 distinct art units. For prosecution planning, attention can be concentrated on the identified examiner and the single outstanding action rather than on coordination across multiple examination assignments.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
100% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BOOSALIS, FANI POLYZOS 1 90.3% +10.8%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19106111 LASER ADAPTER, MULTIPHOTON MICROSCOPE MAIN UNIT AND OPTICAL IMAGING SYSTEM BOOSALIS, FANI POLYZOS —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19106111 LASER ADAPTER, MULTIPHOTON MICROSCOPE MAIN UNIT AND OPTICAL IMAGING SYSTEM BOOSALIS, FANI POLYZOS —

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19106111 LASER ADAPTER, MULTIPHOTON MICROSCOPE MAIN UNIT AND OPTICAL IMAGING SYSTEM BOOSALIS, FANI POLYZOS — §102§103 Non-Final OA — Pending Feb 24, 2025

Managing Beijing Transcend Vivoscope Bio-Technology Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Beijing Transcend Vivoscope Bio-Technology Co. Ltd. have?

Beijing Transcend Vivoscope Bio-Technology Co. Ltd. has 1 pending office actions as of October 2026, spread across 0 art units and 1 examiners.

Which USPTO examiner handles the most Beijing Transcend Vivoscope Bio-Technology Co. Ltd. applications?

Fani Polyzos Boosalis has the most, with 1 of Beijing Transcend Vivoscope Bio-Technology Co. Ltd.'s pending office actions.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month